The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
Open accessAbstract
The earliest recognizable atherosclerotic lesions are fatty streaks composed of lipid-laden macrophages (foam cells). Circulating monocytes are the precursors of these foam cells, but the molecular mechanisms that govern macrophage trafficking through the vessel wall are poorly understood. Monocyte chemoattractant protein-1 (MCP-1), a member of the chemokine (chemotactic cytokine) family, is a potent monocyte agonist that is upregulated by oxidized lipids. Recent studies in hypercholesterolemic mice lacking apo E or the low-density lipoprotein receptor have suggested a role for MCP-1 in monocyte recruitment to early atherosclerotic lesions. To determine if MCP-1 is critically involved in atherogenesis in the setting of elevated physiological plasma cholesterol levels, we deleted the MCP-1 gene in transgenic mice expressing human apo B. Here we report that the absence of MCP-1 provides dramatic protection from macrophage recruitment and atherosclerotic lesion formation in apo B transgenic mice, without altering lipoprotein metabolism. Taken together with the results of earlier studies, these data provide compelling evidence that MCP-1 plays a critical role in the initiation of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,665
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Self-citationBoring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Self-citationApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Self-citationIshibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Rg, G. (1981) · PubMed Central · Cited by 1,314
Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., & Fogelman, A. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5134 · Cited by 1,146
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis
Goldberg, I. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37569-6 · Cited by 1,010
Cell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003
Faggiotto, A., Ross, R., & Harker, L. (1984) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.4.4.323 · Cited by 984
Quantitative assessment of atherosclerotic lesions in mice
Paigen, B., Morrow, A., Holmes, P. A., Mitchell, D., & Williams, R. A. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90202-4 · Cited by 952
Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., & Maeda, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4471 · Cited by 944
Monocyte chemoattractant protein-1 in human atheromatous plaques.
Nelken, N. A., Coughlin, S. R., Gordon, D., & Wilcox, J. N. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115411 · Cited by 880
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
Altered wound healing in mice lacking a functional osteopontin gene (spp1).
Liaw, L., Birk, D. E., Ballas, C. B., Whitsitt, J. S., Davidson, J. M., & Hogan, B. L. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1122 · Cited by 747
Ishibashi, S., Goldstein, J. L., Brown, M. S., Herz, J., & Burns, D. K. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117179 · Cited by 728
Altered wound healing in mice lacking a functional osteopontin gene (spp1).
Liaw, L., Birk, D. E., Ballas, C. B., Whitsitt, J. S., Davidson, J. M., & Hogan, B. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2131 · Cited by 663
Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
Reddick, R. L., Zhang, S. H., & Maeda, N. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.141 · Cited by 633
Sniderman, A., Shapiro, S., Marpole, D., Skinner, B., Teng, B., & Kwiterovich, P. O. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.604 · Cited by 633
Variation in susceptibility to atherosclerosis among inbred strains of mice
PAIGEN, B., MORROW, A., BRANDON, C., MITCHELL, D., & HOLMES, P. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90138-8 · Cited by 612
Rollins, B. J. (1997) · PubMed · Cited by 603
Self-citationTangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
Pászty, C., Maeda, N., Verstuyft, J., & Rubin, E. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117412 · Cited by 374
Synthetic low and high fat diets for the study of atherosclerosis in the mouse.
Nishina, P., Verstuyft, J., & Paigen, B. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42785-3 · Cited by 293
Kim, E., Lowenson, J. D., MacLaren, D. C., Clarke, S., & Young, S. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6132 · Cited by 291
Self-citationRubin, E. M., Ishida, B. Y., Clift, S. M., & Krauss, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.434 · Cited by 274
Farese, R. V., Ruland, S. L., Flynn, L. M., Stokowski, R. P., & Young, S. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1774 · Cited by 258
Self-citationRaabe, M., Flynn, L. M., Zlot, C. H., Wong, J. S., Véniant, M. M., Hamilton, R. L., & Young, S. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8686 · Cited by 256
Self-citationTeng, B., Sniderman, A. D., Soutar, A. K., & Thompson, G. R. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112360 · Cited by 256
Linton, M. F., Farese, R. V., Chiesa, G., Grass, D. S., Chin, P., Hammer, R. E., Hobbs, H. H., & Young, S. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116927 · Cited by 246
Self-citationYu, X., Dluz, S., Graves, D. T., Zhang, L., Antoniades, H. N., Hollander, W., Prusty, S., Valente, A. J., Schwartz, C. J., & Sonenshein, G. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6953 · Cited by 220
Purcell-Huynh, D. A., Farese, R. V., Johnson, D. F., Flynn, L. M., Pierotti, V, Newland, D. L., Linton, M. F., Sanan, D. A., & Young, S. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117915 · Cited by 198
Self-citationYlä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Goldberg, I. J., Steinberg, D., & Witztum, J. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10143 · Cited by 196
Young, S. G., Witztum, J. L., Casal, D., Curtiss, L. K., & Bernstein, S. (1986) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.6.2.178 · Cited by 135
Self-citationRANTES chemokine expression in transplant-associated accelerated atherosclerosis.
Pattison, J. M., Pj, N., Huie, P., Sibley, R. K., & Krensky, A. M. (1996) · PubMed · Cited by 132
Liu, A. C., Lawn, R. M., Verstuyft, J. G., & Rubin, E. M. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39932-6 · Cited by 117
Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).
Callow, M. J., Verstuyft, J. G., Tangirala, R., Palinski, W., & Rubin, E. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118203 · Cited by 103
Véniant, M. M., Pierotti, V, Newland, D., Cham, C. M., Sanan, D. A., Walzem, R. L., & Young, S. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119511 · Cited by 100
Self-citationMonoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B.
Young, S. G., Bertics, S. J., Curtiss, L. K., Casal, D., & Witztum, J. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1101 · Cited by 80
Self-citationTwo new monoclonal antibody-based enzyme-linked assays of apolipoprotein B.
Young, S. G., Smith, R. S., Hogle, D. M., Curtiss, L. K., & Witztum, J. L. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.8.1484 · Cited by 75
Self-citationNielsen, L. B., McCormick, S. P. A., Pierotti, V., Tam‐Amersdorfer, C., Gunn, M. D., Shizuya, H., & Young, S. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29752 · Cited by 71
Self-citationGenetically modified mice for the study of apolipoprotein B
Kim, E. J.-H., & Young, S. G. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32560-8 · Cited by 70
Self-citationSniderman, A. D., Brown, B. G., Stewart, B. F., et al. (1992) · Current Opinion in Lipidology · doi:10.1097/00041433-199204000-00010 · Cited by 59
Paigen, B. J., Albee, D., Holmes, P. A., & Mitchell, D. (1987) · Biochemical Genetics · doi:10.1007/bf00554352 · Cited by 38
Zlot, C. H., Flynn, L. M., Véniant, M. M., Kim, E., Raabe, M., McCormick, S. P. A., Ambroziak, P., McEvoy, L. M., & Young, S. G. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33341-1 · Cited by 22
Self-citation
Cited by
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Self-citationInternational Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Self-citationAging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
Metadata
- Authors
- Gosling, J., Slaymaker, S., Gu, L., Tseng, S., Zlot, C. H., Young, S. G., Rollins, B. J., & Charo, I. F.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-03-15
- Volume
- 103
- Issue
- 6
- Pages
- 773-778
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2125469512
- Cited by
- 660
- References
- 48
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.